Low mitochondrial DNA copy number induces chemotherapy resistance via epithelial-mesenchymal transition by DNA methylation in esophageal squamous cancer cells

被引：17

作者：

Kubo, Yuto ^{[1
]}

Tanaka, Koji ^{[1
]}

Masuike, Yasunori ^{[1
]}

Takahashi, Tsuyoshi ^{[1
]}

Yamashita, Kotaro ^{[1
]}

Makino, Tomoki ^{[1
]}

Saito, Takuro ^{[1
]}

Yamamoto, Kazuyoshi ^{[1
]}

Tsujimoto, Tomoyuki ^{[1
]}

Harino, Takashi ^{[1
]}

Kurokawa, Yukinori ^{[1
]}

Yamasaki, Makoto ^{[1
]}

Nakajima, Kiyokazu ^{[1
]}

Eguchi, Hidetoshi ^{[1
]}

Doki, Yuichiro ^{[1
]}

机构：

[1] Osaka Univ, Grad Sch Med, Dept Gastroenterol Surg, 2-2 E2 Yamadaoka, Suita, Osaka 5650871, Japan

来源：

JOURNAL OF TRANSLATIONAL MEDICINE | 2022年 / 20卷 / 01期

关键词：

Mitochondrial DNA; Epithelial-mesenchymal transition; Esophageal cancer; Chemotherapy; Mitochondrial membrane potential; DNA methylation; PROGNOSIS; CARCINOMA; APOPTOSIS; DYSFUNCTION; SURVIVAL;

D O I：

10.1186/s12967-022-03594-2

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Background Esophageal squamous cell carcinoma (ESCC) is one of the most severe cancers and is characterized by chemotherapy resistance and poor prognosis associated with epithelial-mesenchymal transition (EMT). In a previous study, a low mitochondrial DNA (mtDNA) copy number was associated with poorer prognosis and induced EMT in ESCC. However, the detailed mechanism related to mtDNA copy number and EMT is unclear. The aim of this study was to clarify the mechanism by which a change in mtDNA copy number contributes to EMT and to examine treatment of chemotherapy resistance in ESCC. Methods The association between low mtDNA copy number and chemotherapy resistance was investigated using specimens from 88 patients who underwent surgery after neoadjuvant chemotherapy. Then, the mtDNA content of human ESCC cell lines, TE8 and TE11, was depleted by knockdown of mitochondrial transcription factor A expression. The present study focused on modulation of mitochondrial membrane potential (MMP) and DNA methylation as the mechanisms by which mtDNA copy number affects EMT. mRNA and protein expression, chemotherapy sensitivity, proliferation, MMP and DNA methylation were evaluated, and in vitro and in vivo assays were conducted to clarify these mechanisms. Results ESCC patients with decreased mtDNA copy number who underwent R0 resection after neoadjuvant chemotherapy had significantly worse pathological response and recurrence-free survival. Additionally, low mtDNA copy number was associated with resistance to chemotherapy in vitro and in vivo. mtDNA controlled MMP, and MMP depolarization induced EMT. Depletion of mtDNA and low MMP induced DNA methylation via a DNA methylation transcription factor (DNMT), and a DNMT inhibitor suppressed EMT and improved chemotherapy sensitivity in mtDNA-depleted ESCC cells, as shown by in vitro and in vivo assays. Conclusion This study showed that decreased mtDNA copy number induced EMT via modulation of MMP and DNA methylation in ESCC. Therapeutic strategies increasing mtDNA copy number and DNMT inhibitors may be effective in preventing EMT and chemosensitivity resistance.

引用

页数：21

共 56 条

[1] Oxidative Phosphorylation as an Emerging Target in Cancer Therapy [J].